Has the Appen Ltd share price fallen into the buy zone?

The Appen Ltd (ASX:APX) share price took a tumble yesterday after releasing its full-year results. Has it fallen into the buy zone?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Unfortunately for its shareholders, the Appen Ltd (ASX: APX) share price tumbled 6% yesterday following the release of its full-year results. But does this decline make the language technology company a must buy now?

Here's what you need to know from yesterday's full-year report:

  • Total revenue increased 34% to $111 million
  • Earnings before interest, tax, depreciation, and amortisation (EBITDA) jumped 24% to $17.2 million.
  • Net profit after tax increased 26% to $10.5 million.
  • Earnings per share of 10.8 cents.
  • Targeting mid-to-high teen EBITDA growth in FY 2017.

Overall I thought this was another strong result from this exciting tech company which counts eight of the top ten global technology companies as customers.

A key driver in its top line growth was its Content Relevance segment. Revenue in the segment rose 44% to $73.2 million during the year. This was driven by the ongoing delivery of training data for machine learning-based search and social media services.

Its Language Resources segment put in another solid performance as well. Revenue grew 18% to $37.7 million thanks to the continuing demand for high quality speech data.

Is it a must buy?

Based on yesterday's result Appen's shares are changing hands at a little under 25x full-year earnings.

Whilst this is a touch higher than the average earnings multiple for the information technology industry, I feel it is more than fair for the level of growth it has produced.

Although management expects EBITDA growth to slow a touch in FY 2017, I believe mid-to-high teen earnings growth still makes Appen attractive at its current share price.

With that in mind I would put Appen up there with the likes of Aconex Ltd (ASX: ACX) and Altium Limited (ASX: ALU) as great long-term buy and hold investments.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of ACONEX FPO, Altium, and Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »